Enamel matrix derivative Emdogain as an adjuvant for a laterally-positioned flap in the treatment of gingival recession: an electron microscopic appraisal.
Enamel matrix derivative (EMD), such as Emdogain, has been suggested for the improvement of wound healing in periodontal surgical therapy. The present qualitative study seeks to illustrate the ultrastructural changes associated with a human gingival wound at 10 days after the application of EMD as an adjunct to a laterally-positioned flap in a patient with gingival recession. An otherwise healthy patient, who had been suffering from bilateral gingival recession defects on teeth #23 and #26, was studied. One defect was treated with a laterally-positioned flap, while the other was treated with a combination of EMD and a laterally-positioned flap. Ten days after the operation gingival biopsy specimens were obtained from the dentogingival region and examined using a transmission electron microscope. A considerable difference was found in both the cellular and extracellular phases of EMD and non-EMD sites. The fibroblasts of EMD site were more rounded with plump cytoplasms and euchromatic nuclei. A well-developed rough endoplasmic reticulum and numerous mitochondria could be detected. In contrast, the fibroblasts of non-EMD site were of flattened spindle-like morphology. While the signs of apoptosis could rarely be detected at EMD site, apoptotic bodies and ultra-structural evidence of apoptosis (crescent-like heterochromatic nuclei and dilated nuclear envelopes) were consistent features at non-EMD site. The extracellular matrix at EMD site mainly consisted of well-organised collagen fibres, while non-EMD site contained sparse and incompletely-formed collagen fibres. Coccoid bacteria were noted within the extracellular matrix and neutrophils at non-EMD site. It seems that EMD may enhance certain features of gingival wound healing, which may be attributable to its anti-apoptotic, anti-bacterial or anti-inflammatory properties.
Lafzi
A
A
Department of Periodontics, School of Dentistry, Tabriz University of Medical Sciences, Tabriz, Iran, and Paediatric Neurosurgery, Children's Hospital, Birmingham, AL 35233, USA.
Farahani
R M
RM
Tubbs
R S
RS
Roushangar
L
L
Shoja
M M
MM
D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D017209:Apoptosis / Q000187:drug effects / Q000502:physiology; D048430:Cell Shape; D003094:Collagen / Q000502:physiology / Q000648:ultrastructure; D003746:Dental Enamel Proteins / Q000627:therapeutic use*; D005109:Extracellular Matrix / Q000187:drug effects / Q000502:physiology; D005347:Fibroblasts / Q000473:pathology / Q000648:ultrastructure; D005881:Gingiva / Q000187:drug effects* / Q000473:pathology / Q000601:surgery; D005889:Gingival Recession / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D006801:Humans; D008297:Male; D046529:Microscopy, Electron, Transmission; D019647:Oral Surgical Procedures / Q000379:methods; D010517:Periodontics / Q000379:methods*; D013524:Surgical Flaps / Q000592:standards; D013530:Surgical Wound Infection / Q000517:prevention & control; D016896:Treatment Outcome; D014945:Wound Healing / Q000187:drug effects* / Q000502:physiology
D000900:Anti-Bacterial Agents; D003746:Dental Enamel Proteins; C109069:enamel matrix proteins; D003094:Collagen